GW Pharmaceuticals (GW Pharmaceuticals) Price-to-Tangible-Book : 8.88 (As of May. 13, 2024)

View and export this data going back to . Start your Free Trial

What is GW Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-05-13), GW Pharmaceuticals's share price is $17.00. GW Pharmaceuticals's Tangible Book per Share of Mar. 2021 for the quarter that ended in Mar. 2021 was $1.91. Hence, GW Pharmaceuticals's Price to Tangible Book Ratio of today is 8.88.

The historical rank and industry rank for GW Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

GWPRF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.51 Med: 6.52 Max: 66
Current: 8.9

During the past 13 years, GW Pharmaceuticals's highest Price to Tangible Book Ratio was 66.00. The lowest was 2.51. And the median was 6.52.

GWPRF's Price-to-Tangible-Book is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.41 vs GWPRF: 8.90

A closely related ratio is called PB Ratio. As of today, GW Pharmaceuticals's share price is $17.00. GW Pharmaceuticals's Book Value per Sharefor the quarter that ended in Mar. 2021 was $1.95. Hence, GW Pharmaceuticals's P/B Ratio of today is 8.74.

GW Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for GW Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GW Pharmaceuticals Price-to-Tangible-Book Chart

GW Pharmaceuticals Annual Data

Trend

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Dec19

Dec20

Price-to-Tangible-Book

Get a 7-Day Free Trial

6.49

7.33

12.35

4.49

4.66

GW Pharmaceuticals Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Price-to-Tangible-Book	Get a 7-Day Free Trial															3.85	5.26	3.80	4.66	8.97

Competitive Comparison of GW Pharmaceuticals's Price-to-Tangible-Book

For the Drug Manufacturers - General subindustry, GW Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GW Pharmaceuticals's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GW Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where GW Pharmaceuticals's Price-to-Tangible-Book falls into.

GW Pharmaceuticals Price-to-Tangible-Book Calculation

GW Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2021 )
	=	17.00	/	1.914
	=	8.88

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

GW Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of GW Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

GW Pharmaceuticals (GW Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GW Pharmaceuticals PLC (OTCPK:GWPRF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sovereign House, Chivers Way, Vision Park, Histon, Cambridge, GBR, CB24 9BZ

Website

http://www.gwpharm.com

GW Pharmaceuticals PLC is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The company's lead product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol used for the treatment of a number of rare childhood-onset epilepsy disorders. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. Geographically its presence can be seen across the region of UK, Europe, US, Canada, and others.